|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/546 | |
| A61K 31/431 | |||
| A61K 9/19 | |||
| A61P 31/04 | |||
| A61K 45/06 |
| (11) | Number of the document | 2900244 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13840550.1 |
| Date of filing the European patent application | 2013-09-27 | |
| (97) | Date of publication of the European application | 2015-08-05 |
| (45) | Date of publication and mention of the grant of the patent | 2019-10-23 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2013/062256 |
| Date | 2013-09-27 |
| (87) | Number | WO 2014/052799 |
| Date | 2014-04-03 |
| (30) | Number | Date | Country code |
| 201261706399 P | 2012-09-27 | US |
| (72) |
LAI, Jan-Ji, US
GU, Jian-Qiao, US
PATHARE, Pradip, M., US
JURKAUSKAS, Valdas, US
TERRACCIANO, Joseph, US
MILLER DAMOUR, Nicole, US
|
| (73) |
Merck Sharp & Dohme Corp.,
126 East Lincoln Avenue, Rahway, NJ 07065,
US
|
| (54) | TAZOBACTAM ARGININE ANTIBIOTIC COMPOSITIONS |
| TAZOBACTAM ARGININE ANTIBIOTIC COMPOSITIONS |